Clinical Trial of Trelagliptin Succinate Tablets in the Treatment of Type 2 Diabetes

Clinical trial NCT03940183 · COMPLETED

Trial details

NCT number: NCT03940183
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2019-07-08
Primary completion: 2020-12-03
Enrollment: 254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.